(Albany, US) Delveinsight has launched a new report on Sarcopenia Market
Sarcopenia is a condition which is characterized by loss of muscle mass, muscle strength and functional muscle impairment with ageing. The definition has been through various alterations. However, an enormous recent breakthrough is the inclusion of the condition in the ICD-10 classification of diseases. The physical consequences of this disease put a person at risk for falls, fractures, and hospitalization, thereby affecting the quality of life and death in extreme cases.
The etiology of sarcopenia is a constellation of factors involving the aging neuromuscular machinery (motor unit number and efficiency, muscle architecture and orientation, fiber type distibution), reduced anabolic hormone levels, muscle disuse, and inflammation driven by environmental, genetic and behavioral factors.
Request for free sample page:- https://www.delveinsight.com/sample-request/sarcopenia-market
Sarcopenia Treatment Market
The DelveInsight Sarcopenia market report gives a thorough understanding of the Sarcopenia by including details such as disease definition, symptoms, causes, pathophysiology, diagnosis and treatment. This segment of the report covers the detailed diagnostic methods or tests for Sarcopenia . It covers the details of conventional and current medical therapies available in the Sarcopenia market for the treatment of the condition. It also provides Sarcopenia treatment algorithms and guidelines in the United States, Europe, and Japan.
Sarcopenia Market
Early recognition and intervention is the key to improved outcomes in patients with sarcopenia. Screening patients for impairment in their physical function and activities of daily living (ADLs) should be a routine part of healthcare visits for the elderly. Currently, there are no agents for the treatment of sarcopenia that have been FDA approved. Nutritional supplementation, resistance training, exercise, vibrational therapy constitute the treatment space for sarcopenia. Compared with singular interventions, combined interventions, including comprehensive exercise-based treatment interventions, such as resistance training and nutritional intervention, are effective for improving sarcopenia and are recommended. Assessment of the effect of interventions in research and clinical practice is required to enable them to be targeted appropriately. Unfortunately, no clear consensus has yet been reached regarding which intermediate measures should be used in research settings or clinical guidelines.
Sarcopenia Report Scope
Table of content
1. Key Insights
2. Executive Summary of Sarcopenia
3. Competitive Intelligence Analysis for Sarcopenia
4. Sarcopenia : Market Overview at a Glance
5. Sarcopenia : Disease Background and Overview
6. Patient Journey
7. Sarcopenia Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Sarcopenia Treatment
11. Marketed Products
12. Sarcopenia Emerging Therapies
13. Sarcopenia : Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Sarcopenia
17. KOL Views
18. Sarcopenia Market Drivers
19. Sarcopenia Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
Why should you buy this report?
Related Reports
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Yash BhardwajEmail: Send EmailPhone: +919650213330Address:304 S. Jones Blvd #2432 City: Las VegasState: NVCountry: United StatesWebsite: https://www.delveinsight.com/